Related Experiment Video
Updated: May 3, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
White matter disease as a biomarker for long-term cerebrovascular disease and dementia
Aurauma Chutinet1, Natalia S Rost
1Division of Neurology, Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Thai Red Cross, 1873, Rama IV Road, Bangkok, 10330, Thailand, aurauma@yahoo.com.
Opinion Statement:
White matter disease is commonly detected on brain MRI of aging individuals as white matter hyperintensities (WMH), or 'leukoaraiosis." Over the years, it has become increasingly clear that the presence and extent of WMH is a radiographic marker of small cerebral vessel disease and an important predictor of the lifelong risk of stroke, cognitive impairment, and functional disability. A number of large population-based studies have outlined the significance of WMH as a biomarker for long-term cerebrovascular disease and dementia. In this review, we describe the conceptual framework and methodology that support this association and link the existing knowledge to future lines of investigation in the field.
Insights
White matter hyperintensities (WMH) on brain MRI are markers of small vessel disease in aging individuals. Increased WMH indicate higher lifelong risks for stroke, cognitive decline, and disability.
Area of Science:
- Neuroimaging
- Cerebrovascular Disease
- Aging Research
Background:
- White matter disease is frequently observed in aging brains via MRI as white matter hyperintensities (WMH), also known as leukoaraiosis.
- WMH are recognized as radiographic indicators of underlying small cerebral vessel disease.
- Population-based studies highlight WMH as a significant biomarker for long-term cerebrovascular conditions and dementia risk.
Purpose of the Study:
- To review the conceptual framework and methodologies linking WMH to cerebrovascular disease.
- To connect current knowledge on WMH with future research directions.
- To underscore the predictive value of WMH for stroke, cognitive impairment, and functional disability.
Main Methods:
- Review of existing literature and population-based studies.
- Analysis of conceptual frameworks for understanding WMH.
- Synthesis of current knowledge on WMH as a biomarker.
Main Results:
- WMH are established radiographic markers of small cerebral vessel disease.
- The extent of WMH predicts long-term risk of stroke, cognitive impairment, and functional disability.
- WMH serve as a significant biomarker in population studies for cerebrovascular disease and dementia.
Conclusions:
- The presence and extent of WMH on brain MRI are crucial indicators of cerebrovascular health in aging.
- Understanding WMH is vital for predicting lifelong risks associated with small vessel disease.
- Further research is needed to fully elucidate the implications and management of WMH.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Alzheimer Disease ll: Pathophysiology
Long-term Depression
Calcium Ion Concentration Mechanism
If over...

